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ABSTRACT
Objective: The present study aimed to determine indirect
costs of rheumatoid arthritis (RA) in a sample of patients
followed at a public health-care facility in Brazil. Factors
potentially associated with higher indirect costs in these
patients were also investigated.
Methods: This cross-sectional study included patients
between 18 and 65 years old with RA according to the
American College of Rheumatology criteria. Patients who
were working, on sick leave or retired early due to RA were
invited to participate in the survey. A systematic structured
interview was conducted in all patients including demo-
graphic, socioeconomic, and clinical variables and an experi-
enced rheumatologist examined all patients. Estimates of the
indirect costs in the preceding 12 months were performed
using the human-capital approach based on the society per-
spective. Multiple linear regression models were used to
determine the variables associated with higher indirect costs.
Results: A total of 192 patients were included in the study.
Forty-seven of them (24.5%) had retired early due to RA, 62
others (32.3%) were on sick leave due to RA while 83
patients (43.2%) were working at the time of the interview.
Estimated indirect cost for this population was US$
466,107.81 or US$ 2,423.51 per patient per year. Factors
associated with higher costs were RA poor functional class,
high socioeconomic status and male patients (p < 0.001).
Conclusions: Estimated costs found in our population are
similar to that described in more developed countries. Indi-
rect costs were higher in patients with poor functional
classes, high socioeconomic status, and men.
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Introduction
Rheumatoid arthritis (RA) is a systemic inﬂammatory
disease of unknown etiology, characterized by chronic
polyarthritis. Epidemiological studies have demon-
strated that RA affects about 0.2% to 1.0% of the
population in different parts of Brazil [1,2]. The
disease has signiﬁcant impact on both the patient and
the society, especially considering its morbidity, mor-
tality, adverse effects on quality of life, and economic
impact [3–5]. Functional impairment in patients with
RA and its consequent lower productivity reduce their
capacity to participate actively in the labor market
[6–13]. From the perspective of the society, the losses
associated with decreased productivity in RA patients
include reduced performance while at work, absentee-
ism for short or long periods, and early retirement, all
of which are associated with the high cost of illness
[14–17]. Most recent cost estimates of RA based on
the perspective of the society have shown that indirect
costs (i.e., those resulting from decreased productivity)
are higher than direct costs (i.e., medical and nonmedi-
cal expenses involved in the treatment, including medi-
cation, medical consultations, surgical interventions,
and adjustments in the home environment). Most of
the costs of illness studies of RA have been conducted
in developed nations, including the United States and
Western Europe [5,14–16]. The economic situation of
the country, employment levels, and quality of health
services, education, and social beneﬁts are important
factors that likely inﬂuence the burden a certain
disease will have on the individual’s ability to partici-
pate in the labor market. As a consequence, all these
factors will also affect the economic impact of the
disease in a given population. It is possible that cost
estimates performed in developed countries might not
apply to other populations, especially those living in
poorer nations. Moreover, accurate cost estimates are
highly needed in order that health politics can be prop-
erly planned and put into action. In the present study
we determine indirect costs of RA in patients followed
at a tertiary public health service that is a reference
for rheumatic diseases in Brazil. Potential social- and
disease-related factors associated with higher indirect
costs in these patients are also investigated.
Materials and Methods
Patients
Patients in the outpatient clinics for RA of the Division
of Rheumatology at the Federal University of São
Paulo (UNIFESP) were invited to participate in the
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study. All patients had RA according the American
College of Rheumatology (ACR) criteria (1987) [18].
Patients in the study were 18 to 65 years old and were
either working, on sick leave, or retired early because
of RA. Patients were selected consecutively and based
on convenience—patients who came for consultations
at the Hospital São Paulo Rheumatology outpatient
clinics. Exclusion criteria were cognitive impairment
that would preclude the application of the assessment
questionnaires and patients who were on sick leave or
retired early for causes other than RA.
Data Collection
A systematic structured interview was conducted and a
rheumatologist examined all patients. Demographic,
socioeconomic, and clinical characteristics of the
patients were recorded during the interview as well
as information regarding socioeconomic status [19],
occupation, situation in the labor market, and comor-
bidities. The assessment of RA included disease dura-
tion, functional class according to the ACR criteria
(Class I: able to perform usual activities of daily
living—self-care, vocational, and avocational; Class II:
able to perform usual self-care and vocational activi-
ties, but limited in avocational activities; Class III: able
to perform usual self-care activities, but limited to
vocational and avocational activities; Class IV: limited
to ability to perform usual self-care, vocational, and
avocational activities), [20] and visual analog scale
(VAS) for pain, which consists in a mark the patient
does on a standard 100-mm scale (with a border on
each side, to the left of the “0” mark appears the
indication “no pain at all,” and to the right of the 100
mark “pain as bad as it could be”) that represents his
or her robust quantitative pain measure.
Patients answered two validated questionnaires: the
Health Assessment Questionnaire (HAQ) [21], which
measures patient functional capacity, and the Short
Form-36 Health Status Questionnaire (SF-36) [22] to
assess quality of life. The HAQ queries 20 activities of
daily living (dressing, rising, eating, walking, hygiene,
reach, grip, and usual activities) for which the patient
is asked to respond in four categories as to whether he
or she can perform the activity: “without any difﬁ-
culty” (0), “with some difﬁculty” (1), “with much
difﬁculty” (2), and “unable to do” (3); the use of aids
or devices or physical assistance increases a score of 0
or 1 to 2, to more accurately represent underlying
disability; scores of 3 are not modiﬁed. A score for
each of the eight categories of activities of daily living
is based on the maximum score for any of the two or
three activities in the category. The total score is the
mean of the scores for the eight categories. Scores from
0 to 1 generally represent mild to moderate disability;
1 to 2 represent moderate to severe disability; and 2 to
3 indicate severe to very severe disability. The SF-36 is
a generic questionnaire designed to assess perceived
physical and mental health. The SF-36 contains eight
of the most commonly used dimensions in health
surveys: physical functioning, whole physical function-
ing, bodily pain, general health, vitality, social func-
tioning, emotional functioning, and mental health.
The raw scores are standardized and calculated by
summing the individual item within each scale and
then transforming the individual scale score to a scale
ranging from 0 to 100. A higher score indicates better
health-related quality of life. The eight subscales can
be converted to two summary scales: the physical com-
ponent summary and the mental component summary.
Socioeconomic status classiﬁcation used in the
present study reﬂects the individual and household
purchasing power and takes into account a list of assets
(e.g., residence conditions, electrical appliances, auto-
mobiles) as well as the educational level of the head of
household (e.g., school, college, high school, or post-
graduate). As described, patients are classiﬁed as A1,
A2, B1, B2, C, D, or E depending on their scores. A1
status has the highest purchasing power and E the
lowest. In 2000, the distribution of these socioeconomic
classes in São Paulo was: A1–1%, A2–6%, B1–10%,
B2–16%, C-38%, D-26%, and E-2%. For the pur-
poses of this study, A1 and A2 are considered upper
class with the highest purchasing power; B1 and B2
middle class with an intermediate purchasing power;
and C, D, and E, lower class with the lowest purchasing
power. To assess indirect costs, we used the number of
days absent fromwork due toRA in the previousmonth
and previous year, the time on sick leave (receiving
disability pension), and the time since retirement due to
RA. Swollen and painful joint counts were determined
during physical examination. All patients gave in-
formed consent before entry in the study.
A Brief Description of the Labor Market and Social
Security System in Brazil
Patients were classiﬁed according to their situation in
the labor market in one of three categories: workers,
patients on sick leave, or retired because of RA.
Patients with any kind of paid activity were considered
working. Patients on sick leave were those who were
employed at the time of the study, but on leave because
of RA and receiving disability pension. The last group
consisted of patients who took early retirement
because of RA. In Brazil, social security beneﬁts are
available for people who are medically disabled and
have paid into the system regularly for at least
12 months, either as part of payroll withholding fees
or through individual contributions. If a medical inves-
tigator conﬁrms a person is unable to work because of
disease, the patient is relieved of his or her duties until
recovery or permanent disability is ruled and the
person is then retired because of disability. Employers
are liable for the ﬁrst 15 days of sick leave and the
exceeding period is covered by government social secu-
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rity. Patients retired because of disability are reassessed
every 2 years and, if a person recovers ability to work,
the beneﬁt is then lost. Disability beneﬁts vary from an
average of 80% of the highest contribution salaries
to 91%, depending on the time the patient joined the
social security system. People who retire because of
medical disability usually receive pensions correspond-
ing to an average of 80% of the highest salaries paid
during the contribution period.
Estimate of Indirect Costs
Two different approaches have been used to estimate
indirect costs: the human-capital approach and the
friction-cost [23–26]. The human-capital approach
estimates the productivity losses taking into account
that the value of the lost of production is considered
equal to the discounted present value of future earn-
ings expected over the course of the person’s illness.
The method estimates costs related to the period an
individual was absent from work during the period he
or she would be part of the economically active popu-
lation [23–25]. The friction-cost method takes into
account the potential loss in production for only a
limited period of time before the person is replaced,
and takes into consideration all forms of compensation
for the loss of productivity for short, medium, or long
terms. The duration of the friction period depends on
factors such as unemployment and will vary with the
individual’s education level and skills [26].
The human-capital approach has been criticized but
still is the most used method to evaluate RA cost of
illness, and so we have chosen to use this approach in
our population. In addition, it would be difﬁcult to
estimate the friction period for our population, given
the inﬂuence of speciﬁc factors as mentioned earlier.
Using the human-capital approach to calculate indi-
rect cost of illness means multiplying the number of
days absent from work by the salary paid by the
market to individuals of the same age, sex, and skills
(opportunity cost). The method has been criticized as
it values white men in speciﬁc age brackets over the
elderly, women, or blacks. It is, however, certainly a
more realistic way of estimating cost. The higher value
associated with white men is a natural corollary of
using market salaries as a proxy for the value of
human life. To overcome this socioeconomic bias,
some authors have suggested the use of the average
income of the working population rather than calcu-
lations based on individual estimates [23–25,27].
This study is a preliminary estimate of the indirect
costs associated with the illness based on individual
data. For working patients, the indirect costs were
estimated by multiplying the days absent from work
due to RA symptoms over the past year by the value
of a day’s work for the patient (monthly salary ¥ 12/
365). Absenteeism due to causes other than RA was
excluded. For patients on sick leave or early retirement
due to RA, the indirect costs were estimated by multi-
plying the period away from work or retired during the
past year by the average market salary paid to indi-
viduals with the same qualiﬁcations as the patient, as
published by an institution that conducts monthly
surveys of positions and salaries in São Paulo, Brazil
[28]. Aggregate results or total indirect costs/year for
each group and for the entire sample are expressed in
US dollars (US$1 = R$2.43; Brazilian currency: Real
R$—2005).
Sensitivity Analysis
In order to evaluate the variations in indirect cost
estimates based on individual and population data, we
submitted our results to a sensitivity analysis. New
estimates of the indirect cost of illness were conducted
using the income in number of minimum wages for the
employed population in the Southeast (3.26 minimum
wages), the geographic region to which the city of São
Paulo belongs, and in Brazil as a whole (2.80 minimum
wages) for the year of 2004 (at the time of this analysis
data for the year of 2005 were not available) [29]. In
order to enable the comparison of estimates based on
individual data and those based on population data,
the indirect cost for each patient in Reals (R$) was
converted to the equivalent minimum wage by using
the minimum wage at the time of the interview. The
conversion from Reals (R$) to minimum wage in the
present study was needed because of the current eco-
nomic conditions in Brazil. Workers’ salary (its pur-
chasing power) is systematically deﬂated over time in
our country and that has forced the Brazilian govern-
ment to grant annual rises in the minimum wage in
the last years. Government rises in the minimum wage
have been used as reference for salary adjustments for
the different worker categories in Brazil. For sensitivity
analyses, indirect costs for the entire study population
are expressed in minimum wages/year and the average
in minimum wages/patient/year.
Statistical Analysis
Descriptive analysis of the sample is presented as aver-
ages, standard deviations, and frequencies. Compara-
tive analyses across the different groups used one-
way ANOVA or the nonparametric Kruskal–Wallis,
where more appropriate, or chi-square tests. Using
stepwise and residue analysis, multiple linear regres-
sion models were performed to determine the variables
associated with higher indirect costs. As some vari-
ables showed signiﬁcant nonlinear correlation with
indirect costs, however, costs and some variables were
log-transformed before the analysis. SPSS 13.0 Statis-
tics Package (SPSS, Chicago, IL) was used in all analy-
ses. Signiﬁcance level was set as P < 0.05.
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Results
Demographic and Clinical Characteristics
A total of 192 patients with RA patients were evalu-
ated in the present study between February and
November 2005. Main social, demographic, and clini-
cal characteristics of these patients according to their
working status are shown in Tables 1 and 2. Patients
were 165 women (85.9%) and 27 men (14.1%) aged,
on average, 47.37  9.83 years. Most of the patients
were non-white (60.9%), married (58.9%), and had
less than 8 years of formal education (58.3%). Most of
the patients were in the lowest socioeconomic catego-
ries (C: 49% and D: 35.4%), and comorbidities were
found in 133 patients (69.3%).
Mean disease duration for our sample was
9.79  7.6 years, and 43 patients (22.4%) also had
extra articular manifestations of RA. Most of the
patients were in functional Class II (29.7%) or III
(56.3%). Painful and swollen joints counts at the time
of the interview were, on average, 10.18  9.95 and
12.01  7.19, respectively. Mean VAS for pain and
HAQ scoreswere 48.47  24.90 mmand 1.39  0.69,
respectively. Physical and mental components of the
quality of life questionnaire SF-36 were, on average,
34.18  8.65 and 46.19  12.22, respectively.
At the time of the interview, 47 patients (24.5%)
had been retired early because of RA, 62 others
(32.3%) were on sick leave because of the disease, and
83 patients (43.2%) were working. In the year before
the interview, 45 (23.4%) were retired early because
of RA-related disability; 44 (22.9%) were on sick
leave; 91 (47.4%) were working; 4 (2.1%) were unem-
ployed; and 8 others (2.6%) were not employed, were
not seeking employment, nor were they receiving any
type of disability pension.
Table 1 Social and demographic characteristics of 192 Brazilian patients with rheumatoid arthritis according to work status (retired,
on sick leave, or workers)
Work status Retired N = 47 Sick leave N = 62 Workers N = 83 All N = 192
Age, years (mean SD)* 52.02 7.98 46.52 8.52 45.37 10.89 47.37 9.83
Female, N (%) 41 (87.2) 51 (82.3) 73 (88) 165 (85.9)
Ethnicity, N (%)
White 23 (48.9) 22 (35.5) 30 (36.1) 75 (39.1)
Nonwhite 24 (51.1) 40 (64.5) 53 (63.9) 117 (60.9)
Marital status, N (%)**
Single 10 (21.3) 11 (17.7) 23 (27.7) 44 (22.9)
Married 22 (46.8) 39 (62.9) 52 (62.7) 113 (58.9)
Widowed/separated/divorced 15 (31.9) 12 (19.4) 8 (9.6) 35 (18.2)
Education, years of schooling, N (%)
0 2 (4.3) 0 (0) 4 (4.8) 6 (3.1)
>1 and <8 32 (68.1) 35 (56.8) 39 (47) 106 (55.2)
8–11 11 (23.4) 22 (35.5) 30 (36.1) 63 (32.8)
>11 2 (4.3) 5 (8.1) 10 (12) 17 (8.9)
Socioeconomic category, N (%)*
A and B 3 (6.4) 7 (11.3) 18 (21.7) 28 (14.6)
C 29 (61.7) 23 (37.1) 42 (50.6) 94 (49.1)
D and E 15 (31.9) 32 (51.6) 23 (27.7) 70 (36.5)
*P < 0.001; **P < 0.05.











Comorbidities (mean SD)** 1.91 1.59 1.58 1.36 1.13 1.19 1.47 1.38
Disease duration, years (mean SD)* 16.60 7.77 8.57 6.27 6.85 6.01 9.79 7.63
Painful joints count (mean SD)* 10.17 9.13 12.82 10.24 8.22 8.82 10.18 9.95
Swollen joints count (mean SD) 12.57 8.54 11.56 5.74 12.01 7.40 12.01 7.19
VAS for pain, mm (mean SD)* 45.49 22.65 59.24 21.26 42.12 26.20 48.47 24.90
HAQ (mean SD)* 1.56 0.47 1.77 0.55 1.02 0.72 1.39 0.69
SF-36 Physical score (mean SD)* 33.86 6.75 29.19 6.59 38.10 9.04 34.18 8.65
SF-36 Mental score (mean SD)* 43.79 12.43 43.90 12.86 49.26 11.01 46.19 12.22
Functional class, N (%)*
I 0 (0) 0 (0) 26 (31.3) 26 (13.5)
II 2 (4.3) 0 (0) 55 (66.3) 57 (29.7)
III 45 (95.7) 61 (98.4) 2 (2.4) 108 (56.3)
IV 0 (0) 1 (1.6) 0 (0) 1 (0.5)
*P < 0.001; **P < 0.05.
VAS, visual analog scale; HAQ: Health Assessment Questionnaire; SF-36, Short Form-36 Health Status Questionnaire.
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Comparative analyses between the working status
groups showed statistically signiﬁcant differences in
the variables age (P = 0.002), disease duration
(P = 0.0001), painful joints counts (P = 0.0001), func-
tional class (P = 0.0001), VAS for pain (P = 0.0001),
HAQ scores (P = 0.0001), physical (P = 0.0001) and
mental (P = 0.009) components of the SF-36 question-
naire, and number of comorbidities (P = 0.011). No
statistically signiﬁcant difference between groups was
seen for sex, race, and years of schooling or swollen
joints counts. Retired patients and those on sick leave
tended to belong to the lower socioeconomic catego-
ries, while those who were working were in the higher
classes (P = 0.005; see Tables 1 and 2).
Productivity Losses Assessment and Estimate of
Indirect Costs
According to information reported by the working
patients, mean number of days absent from work
because of RA in the previous month and year was
1.31  2.71 and 14.64  27.95, respectively. About
58 patients (69.9%) denied being absent from work
because of RA over the previous month, and 36
(43.4%) claimed they had not been absent for
RA-related reasons in the past year. Mean time on
disability was 2.25  2.55 years, and mean retirement
time was 7.33  5.39 years. Mean age at the time of
retirement was 44.77  5.39 years.
Indirect costs estimated for this population were
US$466,107.81 (R$1,132,642.00) or US$2427.64
(R$5899.17) per patient per year. Table 3 shows esti-
mated indirect costs for patients according to working
status.
Factors Associated with Higher Indirect Costs
Multiple linear regression analysis was used to deter-
mine the variables associated with higher indirect
costs. Poor functional class, higher socioeconomic
status, and male patients were the variables most sig-
niﬁcantly associated with higher indirect costs in our
sample, and the regression model is shown in Table 4.
The model generated demonstrates that these variables
can explain about 70% of the variability in estimated
indirect costs for this population. RA functional class
was the variable with the best explanatory behavior.
Poorer functional class was signiﬁcantly associated
with higher indirect costs. Accordingly, the better the
patient socioeconomic status, the higher will be the
related indirect costs, and indirect costs in men are
somehow superior to those observed in women.
Sensitivity Analysis
Estimated indirect cost for each patient measured in
Brazilian currency (Real) was transformed into
minimum wage using the minimum wage values at the
time of the interview (from February to April 2005,
1 minimum wage = R$260.00 and from May 2005
onward, 1 minimum wage = R$ 300.00). Indirect costs
related to RA for our population was estimated at
3985.5 minimum wages/year, with an average of 20.75
minimum wages/patient/year.
As shown in Table 5, estimates based on the popu-
lation data, taking into account the income in number
of minimum wages for the employed population in the
Southeast area and in Brazil as a whole, revealed
numbers that are very similar to the estimates based on
individual data. Compared with indirect costs esti-
mated based on individual data, estimates based on
the population income data of the Southeast region
and Brazil as a whole were 0.86% higher and 13.06%
lower, respectively.
Discussion
Data from the present study demonstrated that patients
on sick leave and those who retired early to RA are
mainly responsible for most of the indirect costs asso-
ciated with RA. The indirect costs for the working
group, which correspond to about 43% (N = 83) of the
sample, were signiﬁcantly lower when compared with
those for retired or on sick leave patients. The average
number of days absent from work due to RA observed
in our sample is similar to that found in previously
published data, which have ranged from 2.7 to 30 days
Table 3 Indirect costs of rheumatoid arthritis (RA) estimated
based on individual data for 192 Brazilian patients with RA






Retired (N = 47) 211,172.56 4493.03
Sick leave (N = 62) 245,880.17 3965.80
Worker (N = 83) 9,055.24 109.09
Total (N = 192) 466,107.81 2427.64




(not standardized) Standard deviation
Coefﬁcient
(standardized) b t P
Constant 2.861 0.605 4.732 0.0001
Functional class 2.469 0.133 0.847 18.509 0.0001
Socioeconomic category 0.280 0.110 0.117 2.555 0.012
Gender 0.514 0.236 0.097 2.177 0.031
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absent per patient per year [14,30]. The present study is
the ﬁrst-ever estimate of the indirect costs associated
with RA in the Brazilian population. The results of this
retrospective analysis reveal that the costs associated
with productivity losses in our population, as measured
using the human-capital approach, are considerable
and similar to those observed in developed nations
[14–16,27,30–36]. Socioeconomic characteristics in
Brazil are quite different from that of developed coun-
tries where indirect costs of RA have been estimated,
especially in terms of raw national income and its
heterogeneous distribution. It is then likely that the
impact of the cost values found in the present study on
the Brazilian society may be signiﬁcantly higher than
that observed for other countries. The estimated indi-
rect costs associated with RA per patient per year in
this study is 56% of the national income product per
capita estimated on the basis of per capita prices for the
years 2004 and 2005 in Brazil (US$4284.00 and
US$4320.00, respectively).
Comparing indirect costs associated with RA or
other illnesses between populations is not a straight-
forward process because several factors may affect
the estimates. In addition to differences in the health
systems and social security support available for
patients unable to work because of disease-related
reasons, the study populations are heterogeneous and
the methodologies used to estimate indirect costs
may vary considerably. Including patients more than
65 years of age in RA-related cost studies reduces the
indirect costs estimates, as their role in the economi-
cally active society is smaller. Using the human-capital
approach to estimate indirect costs of illness, some
studies have used individual data and others popula-
tion data for expected incomes. The use of population
data in indirect costs estimates attenuates the differ-
ences resulting from the use of individual data in
human-capital assessments and is preferable for the
purpose of comparing different geographic popula-
tions. Comparative analysis of indirect cost estimates
in RA using human-capital approach and friction cost
analysis has demonstrated that the former yields
higher estimates of the costs. The difference between
cost estimates performed using the two methods to
evaluate RA costs in Germany was about 20% [27].
That discrepancy is a consequence of the fact that
friction cost method does not take into consideration
the productivity losses related to absenteeism for
periods longer than that needed for the replacement of
the sick worker (“friction period”). Moreover, the fric-
tion cost method does not ponder very short periods of
absenteeism [26]. RA is a chronic disease characterized
by ﬂares with higher or lower disease activity. That
considered, it is reasonable to assume that even very
shorts periods of absenteeism (1–3 days) may have an
impact on productivity once these periods become fre-
quent along the course of the disease, and should thus
be taken into consideration. It is also possible that a
patient has been absent from work for a quite signiﬁ-
cant time before a temporary incapacity beneﬁt is
granted. Although many criticisms have been pointed
to the human-capital approach, we believe that the
friction cost method can also be as well censored and
may not be suitable to estimate indirect costs in RA
mainly because of particular characteristics of the
disease.
In our study, RA functional class was the main
predictor of the indirect costs of the disease. Poor
functional classes were associated with the highest
indirect costs in our sample. This ﬁnding is in line with
other studies [34,35]. Leardini et al. have found that
direct and indirect costs increase as RA becomes more
severe, with Class IV patients costing six times as much
as Class I patients [34]. Guillemin et al. have also
found a signiﬁcant association between indirect costs
and poor functional class, with similar costs for Class
I and II patients that have two and three times lower
costs than that associated with Class III and IV
patients, respectively [35]. Our data also show a sig-
niﬁcant correlation between RA indirect costs and
socioeconomic status and sex. RA-related disability to
work has been associated with lower levels of educa-
tion, jobs that demand higher physical strength, higher
HAQ disability scores, longer disease duration, persis-
tent erythrocyte sedimentation rate abnormalities,
patient’s global assessment of the disease, pain and
joints count [37]. It is likely that all these factors
contribute to increased incapacity to work among the
lowest socioeconomic segments of the population. At
same time, patients with the lowest socioeconomic
status usually have less formal education and poor
professional qualiﬁcation with the consequent lowest
paying jobs, which accounts for the lower indirect
costs observed for these patients. In contrast, patients
with higher socioeconomic status tend to be more edu-
cated, professionally qualiﬁed, and hold better paying
jobs so that once their capability to work is compro-
mised, the associated indirect costs are higher. In the
Table 5 Sensitivity analysis of the indirect costs (in minimum wages) of rheumatoid arthritis in Brazil—comparison of estimates based
on individual and population incomes
Indirect cost
(US$) (N = 192)
Estimates based on
individual data
Estimates based on population income data for
the working population in Brazil Southeast area
Estimates based on population income data for
the working population in Brazil
Total 3985.50 4019.86 3465.12
Mean (patient/year) 20.75 20.93 18.04
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present study, higher indirect costs in male patients as
compared with women are explained by the fact that
men in the sample had better paying jobs than women.
These associations reﬂect current discrepancies in the
valuation of the human-capital in our society.
The sensitivity analysis performed to investigate
potential variation between indirect costs measured
based on individual and population data revealed only
minor differences. The comparison of cost values
obtained using individual data and income data for
the working population in the Southeast area of the
country, where São Paulo is located, shows that
population-based estimates are only 0.86% higher
than those based on individual data. This is due to the
fact that the average income for the study participants
is very close to the average income of the Southeast
area working population. Unlike the observations by
Merkesdal et al. [27], in our study the cost estimates
based on the average national income were lower than
those based on individual data. This downward dis-
crepancy between estimates may be explained by the
socioeconomic heterogeneity found across the different
regions in Brazil. The average nominal income for the
working population in the Southeast area is 3.26
minimum wages, almost twice that of the Northeast
region, which has the lowest average income in the
country (1.73 minimum wage). Differences in our esti-
mates, compared with the work by Merkesdal et al.
[27], could also be related to the different methodolo-
gies used to measure average income for the working
populations in Brazil and Germany. In Brazil, the ofﬁ-
cial average income measurements refer only to the
raw monthly income reported by individuals, exclud-
ing some additional incomes such as the 13th salary or
a fund workers can withdraw if they are ﬁred or under
speciﬁc situations such as marriage, buying a home,
etc. [29]. Moreover, Brazil has a signiﬁcant informal
labor force represented by workers who are unregis-
tered and underemployed. According to ofﬁcial data,
laborers in the informal economy in Brazil have
incomes 40% lower than that of the formal economy
[38].
Some limitations of the present study need to be
pointed out in order that an accurate interpretation of
the data can be done. First, the methodology we used
to assess indirect costs in RA patients measured only
losses resulting from absenteeism. Loss of productivity
due to reduced performance while at work (“presen-
teeism”) was not assessed, so the indirect costs associ-
ated with RA are probably underestimated. Recent
evidence suggests that poor performance is the main
determinant factor for productivity losses related to
arthritis in general, and consequently a contributor to
the high indirect costs associated with rheumatic dis-
eases. The higher the difﬁculty reported by patients to
perform their work tasks, the higher would be the loss
of productivity [17]. In a study evaluating work limi-
tations in RA patients using the Work Limitations
Questionnaire, Walker et al. described only a subtle
decline (4.9%) in their productivity. The authors,
however, emphasized that a considerable number of
patients did not answer all of the questions, as they
were considered not applicable to their occupation
[39]. It is not known whether the small decline in
productivity reported in that study is the result of
changes in the work routine and/or switching jobs in a
search for positions that are less subject to the limita-
tions imposed by RA. It is then possible that produc-
tivity declines associated with RA may have been
underestimated in that population [39,40].
A second important limitation of our study is with
regard to data collection and accuracy. Productivity
losses information collected in our study was based on
patient’s report and took into account periods up to
1 month or 1 year before the interview as a reference
for recording data. Ofﬁcial absenteeism records, dis-
ability, and medical retirement beneﬁts are considered
better sources to ensure the reliability of indirect cost
estimates. Nevertheless, the obstacles to obtaining this
information are signiﬁcant. Access to all sources of
payment of salaries and beneﬁts is not easily available
and the economic feasibility of conducting such a
study is questionable. Interestingly, a comparative
analysis of data taken from patient reports and from
payment sources performed by Merkesdal et al. has
revealed striking consistency between the two methods
to assess indirect costs and suggests that RA patients
tend to properly report productivity losses in a period
up to 3 months before data collection [41]. Our
study included information regarding the previous
12 months, a period long enough to allow memory
lapses and less accuracy in data collection. As an alter-
native, shorter periods such as 4 weeks, or even daily
reports, can increase the accuracy of the data collected
in economic analyses [41,42]. Using only the data for
productivity loss for the month before the interview,
the monthly RA-related indirect cost estimated in the
present study would be US$42,445.31 per month or
US$221.15 per patient per month.
We must also keep in mind that this is a cross-
sectional study. For the assessment of predictive factors
of indirect costs, a prospective study would be more
appropriate. Loss of productivity related to RA in
nonpaid activities, such as housewives, students, and
volunteers, was not included in our study, nor did we
consider the repercussions RA might have on the capa-
bility of an unemployed person to ﬁnd a new job.
Taking all of these limitations into consideration, it is
very likely that the economic impact of RA is higher
than has heretofore been estimated.
Finally, many criticisms can be made about assess-
ments of disease-related loss of productivity because
no standard methodology is available. From the
society perspective, however, cost of illness studies
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provide important data on the impact of chronic dis-
eases and help the health system stakeholders identify
priority areas for investment and resource allocation in
order to improve the quality of the actions adopted in
health care. Moreover, the description of costs related
to illness is an important step for complete economic
evaluation that compares new procedures with avail-
able treatments and can be useful when assessing
whether to add new technologies to the health-care
system [43,44].
Financial support: No funding was received for this study.
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